​Sepalika raises $750,000 from Accel

Our Bureaus Mumbai/Ahmedabad | Updated on January 15, 2018 Published on April 28, 2017, a Mumbai-based health content platform that supports those looking to reverse chronic health conditions through guidance on lifestyle, dietary supplements and exercise, has raised $750,000 (Rs 4.80 crore) in its seed round.

The funding round was led by Accel for which the healthcare space is a key sector at the moment.

Sepalika aims to use the fresh capital infused for further building on its research-based content and strengthening its core proposition in the key market of the USA, Sharda Agarwal and Mahesh Jayaraman, Co-Founders, said on Friday.

“Sepalika is delivering on its mission to transform lives with its unique business model. The research-backed content platform aims to bring down the dependence on drugs and partner patients, caregivers, or experts in functional medicine to reverse chronic illnesses,” said Barath Shankar Subramanian, Principal at Accel.

“With people increasingly becoming health-conscious and resorting to natural methods to cure their illnesses, the resources at Sepalika such as use of research-backed dietary supplements, exercise and stress management have a very important role to play in the effort to stay in good health. The platform has tremendous potential to scale and we look forward to working with it towards its larger goal,” he added.

Launched in March 2016, Sepalika makes use of a functional medicine approach to understand the disease at its root cause and address it through a research-backed holistic approach.

Sepalika is a health content platform that partners people looking to reverse chronic diseases through guidance on diet, lifestyle, dietary supplements and exercise along with helping them counter the side effects of prescription drugs.

Currently, Sepalika focuses on 11 chronic health conditions such as Type 2 diabetes, cardiac diseases, hypertension, arthritis, mental health and depression, Alzheimer’s and other dementias, osteoporosis, respiratory illnesses, hypothyroidism, acid reflux and insomnia.

Published on April 28, 2017

A letter from the Editor

Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.